How well do vaccines for Bordetella bronchiseptica work in dogs? A critical review of the literature 1977-2014

Veterinary Journal

Volumn 204, Issue 1, 2015, Pages 5-16

  Ellis, John A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Bordetella bronchiseptica; Canine infectious respiratory disease; Dogs; Injectable vaccine; Intra nasal vaccine; Kennel cough; Oral vaccine

Indexed keywords

BACTERIN; CELL EXTRACT; NEUTRALIZING ANTIBODY; PERTUSSIS VACCINE; BACTERIAL VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BEAGLE; BORDETELLA BRONCHISEPTICA; BORDETELLA BRONCHISEPTICA INFECTION; CONTROLLED STUDY; DOG DISEASE; DRUG EFFICACY; EXPERIMENTAL DESIGN; FEMALE; HERD IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; LONGEVITY; MALE; NONHUMAN; REVIEW; ANIMAL; BORDETELLA INFECTIONS; DOG; DOG DISEASES; IMMUNOLOGY; VETERINARY;

BORDETELLA BRONCHISEPTICA; CANIS FAMILIARIS;

ANIMALS; BACTERIAL VACCINES; BORDETELLA BRONCHISEPTICA; BORDETELLA INFECTIONS; DOG DISEASES; DOGS;

EID: 84928048598     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2015.02.006     Document Type: Review

References (52)

1. Alkire L.T., Chladek D.W. Field evaluation of an intranasally administered canine parainfluenza-Bordetella bronchiseptica vaccine. Veterinary Medicine and Small Animal Clinician 1980, 75:1003-1005.
2. Bemis D.A. Bordetella and Mycoplasma respiratory infections in dogs and cats. Veterinary Clinics of North America Small Animal Practice 1992, 22:1173-1186.
3. Bemis D.A., Greisen H.A., Appel M.J.G. Pathogenesis of canine bordetellosis. Journal of Infectious Diseases 1977, 155:753-762.
4. Bey R.F., Shade F.J., Goodnow R.A., Johnson R.C. Intranasal vaccination of dogs with live avirulent Bordetella bronchiseptica: Correlation of serum agglutination titer and the formation of secretory IgA with protection against experimentally induced infectious tracheobronchitis. American Journal of Veterinary Research 1981, 42:1130-1132.
5. Bradley A., Kinyon K., Frana D., Bolte D., Hyatt D.R., Lappin M.R. Efficacy of intranasal administration of a modified live feline herpesvirus 1 and feline calicivirus vaccine against disease caused by Bordetella bronchiseptica after experimental challenge. Journal of Veterinary Internal Medicine 2012, 26:1121-1125.
6. Brown A.L., Frantz J.C., Peetz R.H. Bordetella bronchiseptica vaccine 1989, United States Patent 4, 888,169, 1989.
7. Buhles W., Kass P.H. Understanding and evaluating veterinary clinical research. Journal of the American Animal Hospital Association 2012, 48:286-298.
8. Chladek D.W., Williams J.M., Gerber D.L., Harris L.L., Murdock F.M. Canine parainfluenza-Bordetella bronchiseptica vaccine immunogenicity. American Journal of Veterinary Research 1981, 42:266-270.
9. Dalmia N., Ramsay A.J. Prime-boost approaches to tuberculosis vaccine development. Expert Review of Vaccines 2012, 11:1221-1230.
10. Davis R., Jayapppa H., Abdelmagid O.Y., Armstrong R., Sweeney D., Lehr C. Comparison of the mucosal immune response in dogs vaccinated with either an intranasal avirulent live culture or subcutaneous antigen extract vaccine of Bordetella bronchiseptica. Veterinary Therapeutics 2007, 8:32-40.
11. Edinboro C.H., Ward M.P., Glickman L.T. A placebo-controlled trial of two intranasal vaccines to prevent tracheobronchitis (kennel cough) in dogs entering a humane shelter. Veterinary Microbiology 2004, 62:89-99.
12. Ellis J., Rhodes C., Lacoste S., Krakowka S. Antibody responses to Bordetella bronchiseptica in vaccinated and infected dogs. Canadian Veterinary Journal 2014, 55:857-864.
13. Ellis J.A., Haines D.M., West K.H., Burr J.H., Dayton A., Townsend H.G., Kanara E.W., Konoby C., Crichlow A., Martin K., et al. Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs. Journal of the American Veterinary Medical Association 2001, 218:367-375.
14. Ellis J.A., Krakowka G.S., Dayton A.D., Konoby C. Comparative efficacy of an injectable vaccine and an intranasal vaccine in stimulating Bordetella bronchiseptica-reactive antibody responses in seropositive dogs. Journal of the American Veterinary Medical Association 2002, 220:43-48.
15. Ellis J.A., Anseeuw E., Gow S., Bryan H., Salb A., Goji N., Rhodes C., La Coste S., Smits J., Kutz S. Seroepidemiology of respiratory (group 2) canine coronavirus, canine parainfluenza virus, and Bordetella bronchiseptica infections in urban dogs in a humane shelter and rural dogs in small communities. Canadian Veterinary Journal 2011, 52:861-868.
16. Ferry N.S. A preliminary report of bacterial findings in canine distemper. American Veterinary Review 1910, 37:499-504.
17. Foley J.E., Rand C., Bannasch M.J., Norris C.R., Milan J. Molecular epidemiology of feline bordetellosis in two animal shelters in California, USA. Preventative Veterinary Medicine 2002, 54:141-156.
18. Ford R.B. Canine infectious tracheobronchitis. Infectious Diseases of the Dog and Cat 2006, 54-61. Saunders, Philadelphia, PA, USA. Third Ed. C.E. Greene (Ed.).
19. Glickman L.T., Appel M.J. Intranasal vaccine trial for canine infectious tracheobronchitis (kennel cough). Laboratory Animal Science 1981, 31:397-3999.
20. Goodnow R.A. Biology of Bordetella bronchiseptica. Microbiological Reviews 1980, 44:722-738.
21. Goodnow R.A., Shade F.J. Control of bordetellosis in the dog. Canine Practice 1979, 6:43-46.
22. Goodnow R.A., Shade F.J. Control of canine bordetellosis. Modern Veterinary Practice 1980, 61:597-598.
23. Gore T., Headley M., Laris R., Bergman J.G.H.E., Sutton D., Horspool L.J.I., Jacobs A.A.C. Intranasal kennel cough vaccine protecting dogs from experimental Bordetella bronchiseptica challenge within 72 hours. Veterinary Record 2005, 156:482-483.
24. Gupta R.K., Sharma S.B., Ahuja S., Saxena S.N. The effects of different inactivating agents on the potency, toxicity, and stability of pertussis vaccine. Journal of Biological Standards 1987, 15:87-93.
25. Hess T.J., Parker D.S., Hassall A.J., Chiang Y.W. Evaluation of efficacy of oral administration of Bordetella intranasal vaccine when used to protect puppies from tracheobronchitis due to B. Bronchiseptica infection. International Journal of Applied Research in Veterinary Medicine 2011, 9:301-305.
26. Iemura R., Tsukatani R., Micallef M.J., Taneno A. Simultaneous analysis of the nasal shedding kinetics of field and vaccine strains of Bordetella bronchiseptica. Veterinary Record 2009, 165:747-751.
27. Jacobs A.A.C., Theelen R.P.H., Jaspers R., Horspool L.J., Sutton D., Bergman J.G., Paul G. Protection of dogs for 13 months against Bordetella bronchiseptica and canine parainfluenza virus with modified-live vaccine. Veterinary Record 2005, 157:19-23.
28. Jafari H., Deshpande J.M., Sutter R.W., Bahl S., Verma H., Ahmad M., Kunwar A., Vishwakarma R., Agarwal A., Jain S., et al. Efficacy of inactivated poliovirus vaccine in India. Science 2014, 345:922-925.
29. Keil D.J., Fenwick B. Role of Bordetella bronchiseptica in infectious tracheobronchitis in dogs. Journal of the American Veterinary Medical Association 1998, 212:200-207.
30. Kontor E.J., Wegrzyn R.J., Goodnow R.A. Canine tracheobronchitis: Effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough). American Journal of Veterinary Research 1981, 42:1694-1698.
31. Kumar H., Kawai T., Akira S. Pathogen recognition by the innate immune system. International Review of Immunology 2011, 30:16-34.
32. Larson L.J., Thiel B.E., Sharp P., Schultz R.D. A comparative study of protective immunity provided by oral, intranasal and parenteral canine Bordetella bronchiseptica vaccines. International Journal of Applied Research in Veterinary Medicine 2013, 11:153-160.
33. Lavine J.S., King A.A., Bjornstad O.N. Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proceedings of the National Academy of Sciences of the United States of America 2011, 7259-7264.
34. Lehr C., Jayappa H., Erskine J., Brown A., Sweeney D., Wassmoen T. Demonstration of 1 year duration of immunity for attenuated Bordetella bronchiseptica vaccine in dogs. Veterinary Therapeutics 2008, 9:257-262.
35. Locht C. A common vaccination strategy to solve unsolved problems of tuberculosis and pertussis. Microbes and Infection 2008, 10:1051-1056.
36. Lu S. Heterologous prime-boost vaccination. Current Opinion in Immunology 2009, 21:346-351.
37. Mattoo S., Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clinical Microbiology Reviews 2005, 18:326-382.
38. Matzinger P. Tolerance, danger, and the extended family. Annual Review of Immunology 1994, 12:991-1045.
39. McCandlish I.A.P., Thompson H. Vaccination against Bordetella bronchiseptica infection in dogs using a heat-killed bacterial vaccine. Research in Veterinary Science 1978, 25:45-50.
40. McCandlish I.A.P., Thompson H. Vaccination against canine bordetellosis using an aluminum hydroxide adjuvant vaccine. Research in Veterinary Science 1978, 25:51-57.
41. McCandlish I.A.P., Thompson H. Vaccination against canine bordetellosis: Protection from contact challenge. Veterinary Record 1978, 102:479-483.
42. McCandlish I.A.P., Thompson H., Wright N.G. Kennel cough: Vaccination against Bordetella bronchiseptica infection. Veterinary Record 1976, 98:156-157.
43. Shade F.J., Goodnow R.A. Intranasal immunization of dogs against Bordetella bronchiseptica-induced tracheobronchitis (kennel cough) with modified live-Bordetella bronchiseptica vaccine. American Journal of Veterinary Research 1979, 40:1241-1243.
44. Shade F.J., Rapp V.J. Studies of a bacterin incorporating an extracted Bordetella bronchiseptica antigen for controlling canine bordetellosis. Veterinary Medicine and Small Animal Clinician 1982, 77:1635-1639.
45. Shelton M.E., Draper D.D., Farrington D.O. Control of a tracheobronchitis epizootic associated with Bordetella bronchiseptica in a closed dog colony. Veterinary Medicine and Small Animal Clinician 1977, 72:189-193.
46. St-Pierre N.R. Design and analysis of pen studies in the animal sciences. Journal of Dairy Science 2007, 90:E87-E89.
47. Thrusfield M.V., Aitken C.G.G., Muirhead R.H. Field investigation of kennel cough: Efficacy of vaccination. Journal of Small Animal Practice 1989, 30:550-560.
48. Tizard I. Immunity at body surfaces. Veterinary Immunology, an Introduction 2013, 240-257. WB Saunders, Philadelphia, PA, USA. Ninth Ed.
49. Tizard I. B cells and their response to antigens. 2013. Veterinary Immunology, an Introduction 2013, 150-164. WB Saunders, Philadelphia, PA, USA. Ninth Ed.
50. Todd J.D., Volenec F.J., Paton I.M. Interferon in nasal secretions and sera of calves after intranasal administration of avirulent infectious bovine rhinotracheitis virus: Association of interferon in nasal secretions with early resistance to challenge with virulent virus. Infection and Immunity 1973, 5:699-706.
51. Wright N.G., Thompson H., Taylor D., Cornwell H.J.C. Bordetella bronchiseptica: A re-assessment of its role in canine respiratory disease. Veterinary Record 1973, 93:486-487.
52. Wright P.F., Nilsson E., Van Rooij E.M.A., Lelenta M., Jeggo M.H. Standardisation and validation of enzyme-linked immunosorbent assay techniques for the detection of antibody in infectious disease diagnosis. Revue Scientifique et Technique/Office International des Épizooties 1993, 12:435-450.